Literature DB >> 12225367

Mechanism of induction of complement susceptibility of erythrocytes by spider and bacterial sphingomyelinases.

Denise V Tambourgi1, Marcelo De Sousa Da Silva, Stephen J Billington, Rute M Gonçalves De Andrade, Fábio C Magnoli, J Glenn Songer, Carmen W Van Den Berg.   

Abstract

We have recently shown that the sphingomyelinase toxins P1 and P2 from the venom of the spider Loxosceles intermedia induce complement (C)-dependent lysis of autologous erythrocytes by induction of the cleavage of cell surface glycophorins through activation of an endogenous metalloproteinase facilitating the activation of the alternative pathway of C. Phospholipase D (PLD) from Corynebacterium pseudotuberculosis shows some degree of homology with the spider sphingomyelinases and can induce similar clinical symptoms to those observed after spider envenomation. The aim of this study was to investigate if the bacterial PLD-induced haemolysis of human erythrocytes was C dependent and if cleavage of glycophorins occurred. We show here that haemolysis of both PLD- and P1-treated human erythrocytes was C dependent, but while PLD-mediated haemolysis was dependent on activation of the classical pathway of C, P1 induced lysis via both the classical and alternative pathways. P1, but not PLD, induced cleavage of glycophorins and no change in expression of complement regulators was induced by either of the toxins. In both cases, annexin V binding sites were exposed, suggesting that the membrane asymmetry had been disturbed causing exposure of phosphatidylserine to the cell surface. Our results suggest that C susceptibility induced by L. intermedia and C. pseudotuberculosis PLD is a result of exposure of phosphatidylserine, and the higher potency of P1 toxin can be explained by its additional effect of cleavage of glycophorins.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12225367      PMCID: PMC1782781          DOI: 10.1046/j.1365-2567.2002.01483.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  41 in total

1.  A clinical and epidemiological study of Loxosceles spider envenoming in Santa Catarina, Brazil.

Authors:  U M Sezerino; M Zannin; L K Coelho; J Gonçalves Júnior; M Grando; S G Mattosinho; J L Cardoso; V R von Eickstedt; F O França; K C Barbaro; H W Fan
Journal:  Trans R Soc Trop Med Hyg       Date:  1998 Sep-Oct       Impact factor: 2.184

Review 2.  Pathophysiologic implications of membrane phospholipid asymmetry in blood cells.

Authors:  R F Zwaal; A J Schroit
Journal:  Blood       Date:  1997-02-15       Impact factor: 22.113

3.  Coordinator's report: glycophorin/band 3 and associated antigens.

Authors:  M E Reid; E Lisowska; D Blanchard
Journal:  Transfus Clin Biol       Date:  1997       Impact factor: 1.406

4.  Interaction between terminal complement proteins C5b-7 and anionic phospholipids.

Authors:  C Liu; P Marshall; I Schreibman; A Vu; W Gai; M Whitlow
Journal:  Blood       Date:  1999-04-01       Impact factor: 22.113

5.  Activation of the alternative pathway of complement by calcium-loaded erythrocytes resulting from loss of membrane phospholipid asymmetry.

Authors:  S T Test; J Mitsuyoshi
Journal:  J Lab Clin Med       Date:  1997-08

6.  Sphingomyelinases in the venom of the spider Loxosceles intermedia are responsible for both dermonecrosis and complement-dependent hemolysis.

Authors:  D V Tambourgi; F C Magnoli; C W van den Berg; B P Morgan; P S de Araujo; E W Alves; W D Da Silva
Journal:  Biochem Biophys Res Commun       Date:  1998-10-09       Impact factor: 3.575

7.  Loxosceles arizonica bite associated with shock.

Authors:  T A Bey; F G Walter; W Lober; J Schmidt; R Spark; P M Schlievert
Journal:  Ann Emerg Med       Date:  1997-11       Impact factor: 5.721

8.  Targeted mutagenesis of the phospholipase D gene results in decreased virulence of Corynebacterium pseudotuberculosis.

Authors:  P J McNamara; G A Bradley; J G Songer
Journal:  Mol Microbiol       Date:  1994-06       Impact factor: 3.501

9.  Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently labeled annexin V.

Authors:  F A Kuypers; R A Lewis; M Hua; M A Schott; D Discher; J D Ernst; B H Lubin
Journal:  Blood       Date:  1996-02-01       Impact factor: 22.113

10.  Toxic phospholipases D of Corynebacterium pseudotuberculosis, C. ulcerans and Arcanobacterium haemolyticum: cloning and sequence homology.

Authors:  P J McNamara; W A Cuevas; J G Songer
Journal:  Gene       Date:  1995-04-14       Impact factor: 3.688

View more
  11 in total

1.  Brown recluse spider (Loxosceles reclusa) venom phospholipase D (PLD) generates lysophosphatidic acid (LPA).

Authors:  Sangderk Lee; Kevin R Lynch
Journal:  Biochem J       Date:  2005-10-15       Impact factor: 3.857

2.  Complement activation by phospholipids: the interplay of factor H and C1q.

Authors:  Lee Aun Tan; Bingbin Yu; Francis C J Sim; Uday Kishore; Robert B Sim
Journal:  Protein Cell       Date:  2010-12-10       Impact factor: 14.870

3.  Brown recluse spider (Loxosceles reclusa) envenomation leading to acute hemolytic anemia in six adolescents.

Authors:  Jenny McDade; Banu Aygun; Russell E Ware
Journal:  J Pediatr       Date:  2010-01       Impact factor: 4.406

4.  Phospholipase D promotes Arcanobacterium haemolyticum adhesion via lipid raft remodeling and host cell death following bacterial invasion.

Authors:  Erynn A Lucas; Stephen J Billington; Petteri Carlson; David J McGee; B Helen Jost
Journal:  BMC Microbiol       Date:  2010-10-25       Impact factor: 3.605

5.  Phospholipase D toxins of brown spider venom convert lysophosphatidylcholine and sphingomyelin to cyclic phosphates.

Authors:  Daniel M Lajoie; Pamela A Zobel-Thropp; Vlad K Kumirov; Vahe Bandarian; Greta J Binford; Matthew H J Cordes
Journal:  PLoS One       Date:  2013-08-29       Impact factor: 3.240

6.  Recombinant Phospholipase D from Loxosceles gaucho Binds to Platelets and Promotes Phosphatidylserine Exposure.

Authors:  Daniel A Fukuda; Maria C Caporrino; Katia C Barbaro; Maisa S Della-Casa; Eliana L Faquim-Mauro; Geraldo S Magalhaes
Journal:  Toxins (Basel)       Date:  2017-06-13       Impact factor: 4.546

7.  Targeting Loxosceles spider Sphingomyelinase D with small-molecule inhibitors as a potential therapeutic approach for loxoscelism.

Authors:  Priscila Hess Lopes; Mário T Murakami; Fernanda C V Portaro; Kerly Fernanda Mesquita Pasqualoto; Carmen van den Berg; Denise V Tambourgi
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

Review 8.  Brown Spider (Loxosceles) Venom Toxins as Potential Biotools for the Development of Novel Therapeutics.

Authors:  Daniele Chaves-Moreira; Fernando Hitomi Matsubara; Zelinda Schemczssen-Graeff; Elidiana De Bona; Vanessa Ribeiro Heidemann; Clara Guerra-Duarte; Luiza Helena Gremski; Carlos Chávez-Olórtegui; Andrea Senff-Ribeiro; Olga Meiri Chaim; Raghuvir Krishnaswamy Arni; Silvio Sanches Veiga
Journal:  Toxins (Basel)       Date:  2019-06-19       Impact factor: 4.546

9.  Sphingomyelin functions as a novel receptor for Helicobacter pylori VacA.

Authors:  Vijay R Gupta; Hetal K Patel; Sean S Kostolansky; Roberto A Ballivian; Joseph Eichberg; Steven R Blanke
Journal:  PLoS Pathog       Date:  2008-05-23       Impact factor: 6.823

Review 10.  Forty Years of the Description of Brown Spider Venom Phospholipases-D.

Authors:  Luiza Helena Gremski; Hanna Câmara da Justa; Thaís Pereira da Silva; Nayanne Louise Costacurta Polli; Bruno César Antunes; João Carlos Minozzo; Ana Carolina Martins Wille; Andrea Senff-Ribeiro; Raghuvir Krishnaswamy Arni; Silvio Sanches Veiga
Journal:  Toxins (Basel)       Date:  2020-03-06       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.